Aytu Biopharma Inc

General ticker "AYTU" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $11.4M

Aytu Biopharma Inc does not follow the US Stock Market performance with the rate: -30.8%.

Estimated limits based on current volatility of 3.9%: low 1.31$, high 1.41$

Factors to consider:

  • US accounted for 99.6% of revenue in the fiscal year ended 2023-06-30
  • Current price 41.4% below estimated low
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-06-30 to 2026-06-30

  • 2024-06-30 to 2025-06-30 estimated range: [2.36$, 4.44$]
  • 2025-06-30 to 2026-06-30 estimated range: [1.67$, 3.23$]

Financial Metrics affecting the AYTU estimates:

  • Negative: Non-GAAP EPS, $ of -2.86 <= 0.10
  • Negative: Operating cash flow per share per price, % of -7.67 <= 2.35
  • Negative: Operating profit margin, % of -6.09 <= 1.03
  • Negative: negative Net income
  • Negative: Industry earnings per price (median), % of -6.42 <= 1.31

Similar symbols

Short-term AYTU quotes

Long-term AYTU plot with estimates

Financial data

YTD 2022-06-30 2023-06-30 2024-06-30
Operating Revenue $98.32MM $108.37MM $81.00MM
Operating Expenses $208.23MM $125.43MM $86.26MM
Operating Income $-109.91MM $-17.07MM $-5.25MM
Non-Operating Income $1.02MM $0.01MM $-8.82MM
Interest Expense $147.50MM $0.00MM $4.79MM
R&D Expense $14.44MM $4.09MM $2.79MM
Income(Loss) $-108.89MM $-17.05MM $-14.08MM
Taxes $-0.11MM $0.00MM $1.77MM
Profit(Loss) $-108.78MM $-17.05MM $-15.84MM
Stockholders Equity $44.31MM $39.36MM $27.72MM
Inventory $10.85MM $11.99MM $12.63MM
Assets $137.62MM $136.46MM $118.09MM
Operating Cash Flow $-28.82MM $-5.13MM $-1.39MM
Investing Cash Flow $-3.25MM $-0.12MM $-0.33MM
Financing Cash Flow $1.53MM $8.87MM $-1.26MM
Earnings Per Share* $-74.01 $-5.11 $-2.86

* EPS are Split Adjusted, recent splits may be reflected with a delay.